Fig. 2

Intestinal mucin phenotype and aberrant MUC13 expression correlate with worse survival in GC patients. A Kaplan–Meier curve (left-hand side) and Cox-proportional hazards model (right-hand side) for survival analysis between patients with gastric tumors assigned to different mucin phenotypes (A) and showing low, mid, or high mRNA levels of a gastric (MUC1, MUC5AC, MUC6) or intestinal (MUC2, MUC4, MUC13) mucin (B). For the gastric mucins (MUC5AC, MUC6, and MUC1), the mid-level expression data was excluded due to a small number of observations (n ≤ 4). A forest plot of the Cox-proportional hazards model is shown (right). For the Kaplan–Meier curves (left), the P values were calculated using the log-rank test whereas the Wald test statistic was performed for the Cox-proportional hazards model (n for each group is shown on the forest plot)